The Cooper Companies, Inc. (COO)

FairStock Score: 47/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses with durable demand, honest accounting, and a price that leaves room for error. Cooper sells contact lenses and women’s-health products, recurring categories with switching costs and regulatory hurdles. That is a decent moat, though not impenetrable. The filed numbers show lumpiness: in fiscal Q3 2026, the quarter ended 2026-07-31, revenue was $1.1 billion, net income $432.8 million, and diluted EPS $2.24. But fiscal Q2 2026, the quarter ended 2026-04-30, had a net loss of $77.9 million and diluted EPS of -$0.40, while fiscal Q1 2026, ended 2026-01-31, earned $130.8 million, or $0.66 per diluted share. For fiscal 2025, the year ended 2025-10-31, revenue was $4.1 billion and net income $374.9 million, or $1.87 per diluted share, versus $3.9 billion and $392.3 million, or $1.96, in fiscal 2024, ended 2024-10-31. So sales are edging up, but profits have not compounded smoothly. The balance sheet looks reasonable: debt-to-equity is 0.34 and trailing free cash flow is $678 million, a 6.5% FCF yield. FairStock’s calculations at the 2026-10-13 close of $54.59 show a P/E of 18.76, P/B of 1.25, Graham Number of $53.56, and margin of safety of -1.92%. That says the shares are near Graham’s estimate of intrinsic value, not bargain-bin cheap. The FairStock Score is 47/100, Piotroski 4/9, and Altman Z-Score 2.51—mixed but not distressed. The Lynch category is STALWART, based on 9.5% five-year profit growth and 11.0% revenue growth. I would want evidence that the recent profit surge is durable before calling it a compelling value.

In plain English: Cooper makes contact lenses and products for women’s health and fertility. It is profitable and produces cash, but profit has been uneven from quarter to quarter. At the recent price, the shares look close to fair value rather than clearly cheap.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-07-31) · fiscal Q2 2026 10-Q (period ended 2026-04-30) · fiscal Q1 2026 10-Q (period ended 2026-01-31) · fiscal Q3 2025 10-Q (period ended 2025-07-31) · FY2025 10-K (period ended 2025-10-31) · FY2024 10-K (period ended 2024-10-31) · FY2023 10-K (period ended 2023-10-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer